Objective. To asses the burden and correlates of genital warts in women. Methods. We
conducted a population-based cross-sectional study in 69,147 women (18–45 years of age) …

Background. More than 90% of genital warts (GW) cases are caused by human
papillomavirus (HPV) types 6 and 11. The introduction of HPV vaccines necessitates the …

Background Approximately 90% of genital warts (GWs) are caused by human
papillomavirus (HPV) types 6 and 11. Denmark has provided the quadrivalent HPV vaccine …

Background We conducted a large national cohort study to examine the risk of cancer
among men and women with genital warts (GW). Methods By use of the Danish National …

Background Australia has provided free quadrivalent human papillomavirus (HPV) vaccines
to school girls since mid-2007 and a catch-up programme in the community to women aged …

Background Denmark introduced the quadrivalent human papillomavirus vaccine into the
vaccination program for 12-to 15-year-old girls in 2008 to 2009. In 2012, the program was …

Background Human papilloma virus (HPV) types 6 and 11 account for 90 percent of
anogenital warts (AGW). Assessment of a potential reduction of the incidence of AGW …

Objective To measure the effect on genital warts of the national human papillomavirus
vaccination programme in Australia, which started in mid-2007. Design Trend analysis of …

Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years
commenced in Australia in 2007, with catch-up vaccination of females aged 13–26 years …

Objective: This study aimed to determine if the Australian human papillomavirus (HPV)
vaccination programme has had a population impact on presentations of genital warts …